ulipristal acetate has been researched along with Heavy Menstrual Bleeding in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 23 (79.31) | 24.3611 |
| 2020's | 6 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, J; Kim, HG; Kyeong, HK; Na, YJ | 1 |
| Allaire, C; Laberge, PY; Leyland, N; Murji, A; Singh, SS; Vilos, GA | 1 |
| Ekanem, E; Talaulikar, V | 1 |
| Nakano, Y; Osuga, Y; Takanashi, M; Yamauchi, Y | 1 |
| Chodankar, RR; Critchley, HOD; Murray, A; Nicol, M; Whitaker, LHR; Williams, ARW | 1 |
| Barnott, E; Black, L; Gould, A; Jack, A; Kastora, SL; Kounidas, G; Morgan, D; Poobalan, A; Robinson-Burke, T; Urquhart, G | 1 |
| Capmas, P; Fernandez, H; Pourcelot, AG | 1 |
| Ascencio, F; Calaf, J; Español, P; Estadella, J; Perelló, J | 1 |
| Brun, JL; Froeliger, A; Monseau-Thiburce, AC; Rajaonarison, J; Randriamboavonjy, R; Vogler, A | 1 |
| Dutta, D; Powell, M | 1 |
| Irani, S; Pounds, R; Pradhan, P; Woodhead, N | 1 |
| Courtoy, GE; Dolmans, MM; Donnez, J; Donnez, O | 1 |
| Ajossa, S; Cappai, R; Coghe, F; Corda, V; Giancane, E; Mais, V; Marotto, MF; Melis, GB; Neri, M; Orani, MP; Paoletti, AM; Pilloni, M; Piras, B; Ronchi, A; Saba, A; Vallerino, V; Zedda, P | 1 |
| Ghonim, M; Magdy, R; Nabhan, A; Sabbour, M | 1 |
| Barra, V; Bellone, E; Biscione, A; Luisi, S; Severi, FM | 1 |
| Barlow, DH; Bestel, E; Fauser, BC; Lumsden, MA; Terrill, P | 1 |
| Barlow, DH; Bestel, E; Bouchard, P; Donnez, J; Donnez, O; Fauser, BC; Loumaye, E; Nouri, K; Osterloh, I; Palacios, S; Tomaszewski, J; Vázquez, F | 1 |
| Critchley, HO; Whitaker, LH; Williams, AR | 1 |
| Belland, L; Singh, SS | 1 |
| Pérez-López, FR | 1 |
| Cosyns, S; Dony, N; Polyzos, NP | 1 |
| Istre, O | 1 |
| Bouchard, P; Chabbert-Buffet, N | 1 |
| Davies, J; Kadir, RA | 1 |
| Bouchard, P | 1 |
| Bestel, E; Bouchard, P; Donnez, J; Ivanova, T; Jilla, MP; Loumaye, E; Mara, M; Osterloh, I; Puscasiu, L; Tatarchuk, TF; Terrill, P; Ugocsai, G; Zakharenko, NF | 1 |
| Baró, F; Bestel, E; Bouchard, P; Donnez, J; Lemieszczuk, B; Loumaye, E; Nouri, K; Osterloh, I; Selvaggi, L; Sodowski, K; Terrill, P; Tomaszewski, J; Vázquez, F | 1 |
| Stewart, EA | 1 |
| Angiolucci, M; Guerriero, S; Lello, S; Maricosu, G; Marotto, MF; Melis, GB; Orru', MM; Paoletti, AM; Pilloni, M; Piras, B | 1 |
12 review(s) available for ulipristal acetate and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms | 2021 |
Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis.
Topics: Adult; Contraceptive Agents; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms | 2021 |
Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
Topics: Contraceptive Agents, Female; Female; Fertility; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Preoperative Care; Receptors, Progesterone; Uterine Neoplasms | 2017 |
Esmya
Topics: Adult; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Hemorrhage; Uterine Neoplasms | 2016 |
Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review.
Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Treatment Outcome; Uterine Neoplasms | 2018 |
A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids.
Topics: Adult; Amenorrhea; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Randomized Controlled Trials as Topic; Uterine Neoplasms | 2019 |
Selective progesterone receptor modulators.
Topics: Breast Neoplasms; Contraceptives, Postcoital; Endometriosis; Female; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Contemporary management of uterine fibroids: focus on emerging medical treatments.
Topics: Adult; Canada; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms; Watchful Waiting | 2015 |
Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids.
Topics: Administration, Oral; Drug Administration Schedule; Endometrium; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Randomized Controlled Trials as Topic; Receptors, Progesterone | 2017 |
Heavy menstrual bleeding: An update on management.
Topics: Adult; Contraceptive Agents; Disease Management; Female; Hemostasis; Hormones; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norpregnadienes; Quality of Life; Young Adult | 2017 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
5 trial(s) available for ulipristal acetate and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial.
Topics: Adult; Amenorrhea; Double-Blind Method; Female; Humans; Japan; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Time Factors; Treatment Outcome; Uterine Neoplasms | 2021 |
Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Topics: Adolescent; Adult; Amenorrhea; Double-Blind Method; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Uterine Hemorrhage; Uterine Neoplasms | 2014 |
Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Topics: Administration, Oral; Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug Administration Schedule; Endometrium; Europe; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Pelvic Pain; Quality of Life; Time Factors; Treatment Outcome; Tumor Burden; Uterine Neoplasms | 2014 |
Ulipristal acetate versus placebo for fibroid treatment before surgery.
Topics: Administration, Oral; Adult; Anemia; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms; Uterus; Young Adult | 2012 |
Ulipristal acetate versus leuprolide acetate for uterine fibroids.
Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Female; Humans; Injections, Intramuscular; Intention to Treat Analysis; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Uterine Neoplasms; Young Adult | 2012 |
12 other study(ies) available for ulipristal acetate and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Effects of long-term intermittent pharmacological therapy with ulipristal acetate on reducing the volume of uterine fibroids and relieving symptoms.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms | 2023 |
Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Topics: Anemia; Antineoplastic Agents, Hormonal; Contraceptive Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Hematinics; Humans; Iron Compounds; Leiomyoma; Leuprolide; Liver Function Tests; Menorrhagia; Norpregnadienes; Uterine Neoplasms | 2019 |
The endometrial response to modulation of ligand-progesterone receptor pathways is reversible.
Topics: Adenomyosis; Adult; Cross-Sectional Studies; Endometrium; Female; Gene Expression Regulation; Humans; Leiomyoma; Ligands; Menorrhagia; Middle Aged; Norpregnadienes; Receptors, Progesterone; RNA, Messenger; Time Factors; Treatment Outcome; Uterine Neoplasms | 2021 |
Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.
Topics: Acute Disease; Adult; Female; Humans; Menorrhagia; Norpregnadienes; Treatment Outcome; Uterine Hemorrhage | 2018 |
Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Contraceptives, Oral, Hormonal; Drug Resistance; Female; France; Hospitals, University; Humans; Leiomyoma; Leiomyomatosis; Magnetic Resonance Imaging; Menorrhagia; Norpregnadienes; Pelvic Pain; Retrospective Studies; Slovenia; Tumor Burden; Ultrasonography; Uterine Neoplasms; Young Adult | 2018 |
Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
Topics: Adult; Contraceptive Agents, Female; England; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms; Young Adult | 2018 |
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health.
Topics: Adult; Bone Density; Drug Administration Schedule; Female; Humans; Italy; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Quality of Life; Treatment Outcome; Uterine Neoplasms | 2019 |
Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.
Topics: Activities of Daily Living; Adult; Anxiety; Contraceptive Agents, Hormonal; Depression; Dysmenorrhea; Dyspareunia; Female; Humans; Leiomyoma; Libido; Menorrhagia; Metrorrhagia; Middle Aged; Neoplasms, Multiple Primary; Norpregnadienes; Pelvic Pain; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Sexual Health; Treatment Outcome; Uterine Neoplasms | 2020 |
Can ulipristal acetate be a treatment option for patients with menorrhagia and a history of ischemic cerebrovascular accident?
Topics: Anemia, Iron-Deficiency; Brain Ischemia; Contraceptive Agents; Disease Management; Female; Humans; Iron; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Trace Elements; Treatment Outcome | 2016 |
Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
Topics: Delayed Diagnosis; Denmark; Disease Progression; Female; Humans; Hysterectomy; Intraoperative Period; Laparoscopy; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Morcellation; Norpregnadienes; Uterine Neoplasms | 2017 |
Uterine fibroids and evidence-based medicine--not an oxymoron.
Topics: Female; Humans; Leiomyoma; Leuprolide; Menorrhagia; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms | 2012 |
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment.
Topics: Adult; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Female; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Mifepristone; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Neoplasms | 2012 |